The Drosophila immune system discriminates between different classes of infectious microbes and responds with pathogen-specific defense reactions through selective activation of the Toll and the immune deficiency (Imd) signaling pathways. The Toll pathway mediates most defenses against Gram-positive bacteria and fungi, whereas the Imd pathway is required to resist infection by Gram-negative bacteria. The bacterial components recognized by these pathways remain to be defined. Here we report that Gram-negative diaminopimelic acid-type peptidoglycan is the most potent inducer of the Imd pathway and that the Toll pathway is predominantly activated by Gram-positive lysine-type peptidoglycan. Thus, the ability of Drosophila to discriminate between Gram-positive and Gram-negative bacteria relies on the recognition of specific forms of peptidoglycan.
The Drosophila immune system detects bacteria through specific peptidoglycan recognition
The innate immune response is activated by receptors that recognize microbial surface determinants that are conserved among microbes but are absent in the host, such as lipopolysaccharide (LPS), peptidoglycan and mannan 1 . On recognition, these receptors activate signaling cascades that regulate the transcription of target genes encoding regulator and effector molecules. A transcription profile specific to one class of pathogen can be achieved when recognition receptors are linked to distinct signaling pathways.
Drosophila lacks an adaptive immune system and relies solely on innate immune reactions for its defense 2, 3 . A hallmark of the Drosophila immune response is the synthesis by the fat body of several antimicrobial peptides with distinct but overlapping specificity. These peptides are secreted into the hemolymph, where they directly kill invading microorganisms. Genetic analyses show that antimicrobial peptide genes are regulated by the Toll and Imd pathways. These two pathways share many common features with the mammalian Toll-like receptor (TLR) and tumor necrosis factor-α (TNF-α) receptor signaling cascades that regulate NF-κB transcription factors 3, 4 . Each of these pathways leads to the activation of specific NF-κB transactivators, which in turn activate specific programs of transcription 5, 6 . The Toll pathway is triggered by the proteolytic cleavage of the Toll ligand Spätzle (Spz) and leads to activation of two Rel proteins, Dorsal immune-related factor and Dorsal. This pathway is activated mainly by Gram-positive bacteria and fungi, and it largely controls the expression of genes encoding antimicrobial peptides (such as Drs, which encodes drosomycin) that are active against fungi [7] [8] [9] [10] [11] . In contrast, the Imd pathway responds mainly to Gram-negative bacterial infection, and it controls the expression of genes encoding antibacterial peptides (such as Dpt, encoding diptericin) through activation of another Rel protein, Relish (encoded by Rel) 8, 12 . Thus, the control of antimicrobial peptide genes by the Toll and Imd pathways provides a good model of the regulation of innate immune responses in animals and shows how two distinct signaling pathways can generate complex transcriptional patterns in response to different pathogens.
Microbial recognition acting upstream of the Toll and Imd pathways is achieved, at least in part, through peptidoglycan recognition proteins (PGRPs). These proteins bind to peptidoglycan, a component of the bacterial envelope, and are found in many species including insects and mammals 13, 14 . Thirteen PGRPs have been identified in Drosophila 15 , of which three are currently implicated in the immune response. PGRP-SA, an extracellular recognition factor, activates the Toll pathway in response to Gram-positive bacterial but not fungal infection 16 . PGRP-LC, a putative transmembrane protein, acts upstream of the Imd pathway [17] [18] [19] . PGRP-LE, a secreted PGRP, can activate the Imd pathway when overexpressed in flies, although determination of its exact function in the Drosophila immune response awaits loss-of-function analysis 20 . Despite the identification of some of the recognition proteins acting upstream of the Toll and Imd pathways, the microbial compounds that are recognized by the Drosophila immune system during the course of an infection have not been characterized. All of the genetic studies showing that the Imd pathway responds to Gram-negative bacterial infection and that the Toll cascade defends against Gram-positive bacteria and fungi [7] [8] [9] [10] [11] have been done with live bacteria.
The presence of lipopolysaccharide (LPS) exclusively on the surface of Gram-negative bacteria has led to the assumption that LPS recognition by the fly immune system is a key step in discriminating between Gram-negative and Gram-positive bacteria. To test this assumption, we have purified components of various bacterial extracts and assayed their ability to induce the Toll and Imd pathways. Here we report that the ability of Drosophila to discriminate between Gram-positive and Gram-negative bacteria is not based on the detection of LPS but rather on the recognition of specific forms of peptidoglycan.
Results

LPS does not induce Dpt expression in vivo
The Dpt gene encodes an antibacterial peptide secreted by the fat body in response to bacterial infection. This gene is tightly regulated by the Imd pathway, and its expression profile provides an accurate readout of Imd pathway activity. To elucidate the microbial determinants that activate the Imd pathway, we purified components of various bacterial extracts and used a glass needle to inject them into the body cavities of adult flies carrying a Dpt-lacZ transgene. β-Galactosidase activity generated by the reporter gene was measured in whole flies collected 6 h after challenge. Because the injection procedure creates an injury that by itself triggers significant induction of the Dpt gene, we compared all β-galactosidase activities to those obtained after control injections of water (Methods).
One of the most potent activators of vertebrate innate immune responses is LPS, a principal component of the Gram-negative bacterial outer envelope 21, 22 . Several previous studies have shown that commercial LPS preparations induce the expression of antibacterial peptide genes in Drosophila 23, 24 ; however, our injections of highly purified LPS from two Gram-negative bacteria, Salmonella typhimurium and Escherichia coli, did not stimulate the expression of Dpt-lacZ as compared with control water injections (Fig. 1a) .
In contrast, the same LPS preparations efficiently activated mouse macrophages through a TLR4-dependant pathway (data not shown). Purified bacterial components were injected into female adult flies carrying a DptlacZ reporter gene. β-Galactosidase activity was measured in four flies collected 6 h after challenge and normalized to the value obtained after injection of water (set at 100%). Bars represent the mean ± s.d. of four independent experiments. Flies were injected with commercial LPS, purified LPS extracted from E. coli or S. typhimurium,
.As a positive control, flies were injected with increasing concentrations (measured by optical density; OD) of an overnight suspension of E. coli (1106) or P. aeruginosa (PAO1).This experiment was repeated twice with similar results. (b) Time course of Dpt gene expression after injecting Gram-negative PG. Quantitative real-time PCR analysis was done on total RNA extracts from Oregon wildtype female flies collected at the indicated intervals after injecting water or 60 µg/ml of E. coli (1106) PG.This experiment was repeated twice with similar results. (c) Effect of the ∆lpp mutation on the ability of E. coli to induce Dpt. β-Galactosidase activity was measured in females carrying the Dpt-lacZ gene collected 6 h after challenge with either a needle dipped in a concentrated pellet (OD 100) of E. coli (BW25113) or ∆lpp E. coli (left) or with 60 µg/ml of PG extracted from E. coli (BW25113) or ∆lpp E. coli (right). C, unchallenged flies. (d) LPS and Gram-negative PG do not activate Dpt synergistically. Flies were injected with purified LPS, purified LPS plus Gram-negative PG, or commercial LPS from E. coli. PG was extracted and purified from E. coli (1106), and LPS was extracted and purified from E. coli (0111B4). 
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, however, injection of commercial LPS activated the Dpt reporter gene (Fig. 1a) . These results suggest that LPS is not the main determinant for recognition of Gram-negative bacteria in flies and that, as previously reported 25 , commercial LPS preparations are contaminated by additional bacterial components (see below).
Dpt is induced by Gram-negative peptidoglycan
As PGRP-LC is reported to be a putative transmembrane receptor that functions upstream of the Imd pathway [17] [18] [19] , we tested the effect of purified peptidoglycan on expression of Dpt-lacZ. We extracted and purified peptidoglycan from two Gram-negative bacteria (E. coli 1106 and Pseudomonas aeruginosa PAO1).
Injection of these Gram-negative bacteria-derived peptidoglycans strongly induced expression of the Dpt-lacZ gene (Fig. 1a) : the stimulatory effect was detected in flies injected with a solution of 5 µg/ml of peptidoglycan and reached a maximum at about 50 µg/ml of peptidoglycan. The expression of Dpt-lacZ induced by these peptidoglycan injections was 2-5 times higher than that induced by control water injections ( Fig. 1 and Table 1 ). The difference in the induction from one experiment to another was due to the injection procedure (Methods). But the stimulatory effects of Gram-negative peptidoglycans were statistically significant ( Table 1 ) and were similar to the induction observed with live E. coli or P. aeruginosa under the same injection conditions (Fig. 1a) . Injecting more than 500 µg/ml of peptidoglycan induced less expression of DptlacZ, a trend that we also observed after injecting increasing amounts of a concentrated pellet of E. coli and P. aeruginosa (Fig. 1a) .
We corroborated our results from the Dpt-lacZ reporter gene assays by quantitative real-time polymerase chain reaction (PCR) analysis of Dpt expression. Dpt expression increased three-to fivefold after injection of Gram-negative peptidoglycan as compared with injection of water (Fig. 1b) . The induction of Dpt gene was similar to the expression kinetics observed after injections with live E. coli 7 , although E. coli induced higher expression of Dpt at later time points (Fig. 1b) .
Lipoproteins are also major components of the Gram-negative bacterial cell wall. In E. coli only one lipoprotein, Lpp, is known to be covalently bound to peptidoglycan 26 . The Gram-negative peptidoglycan preparations that we used were extracted and purified by a procedure that removes all of the proteins associated with peptidoglycan except for two amino acids, lysine and arginine, at the carboxy terminus of the E. coli Lpp lipoprotein that remain bound to some diaminopimelic (DAP) residues of the purified peptidoglycan backbone 27 . To determine whether the Dpt induction that we observed after peptidoglycan injections was caused by Lpp contamination, we generated an E. coli strain lacking the lpp gene (∆lpp). The Dpt-lacZ reporter gene was induced to the same extent after injections of live wild-type E. coli and the live ∆lpp mutant (Fig. 1c) . Purified peptidoglycans extracted from both of these strains also induced similar expression of Dpt-lacZ, confirming that the stimulatory effect of our preparation was due only to peptidoglycan (Fig. 1c) .
Although purified LPS alone did not induce Dpt-lacZ expression, we considered that LPS and Gram-negative bacterial peptidoglycan might interact synergistically to induce Dpt. In addition, it has been proposed that PGRP-LC might bind to both peptidoglycan and LPS as part of a recognition complex 17 . To test this possibility, we monitored Dpt-lacZ expression after injecting solutions containing both Gram-negative bacterial peptidoglycan and increasing amounts of highly purified LPS. The addition of LPS did not increase the peptidoglycan-induced expression of Dpt-lacZ (Fig. 1d) .
Gram-negative peptidoglycan activates the Imd pathway
To determine whether the induction of Dpt expression by Gram-negative peptidoglycan is mediated by the Imd pathway, we injected Gram-negative peptidoglycan into flies carrying mutations affecting components of this pathway: key 1 is a modification in kenny, which encodes the IKKγ subunit of the Drosophila IKK complex, and PGRP-LC ∆E is a mutation in PGRP-LC, which encodes a putative receptor in the Imd cascade 10, [17] [18] [19] . Induction of Dpt-lacZ expression by Gram-negative peptidoglycan was completely abolished in both key 1 and PGRP-LC ∆E flies (Fig. 2a) . In contrast, spz rm7 , a mutation in spz, which encodes the putative ligand of the Toll receptor, and PGRP-SA seml , a mutation in PGRP-SA, which encodes a recognition protein that activates the Toll pathway in response to Gram-positive bacterial infection 16 , did not affect Dpt-lacZ induction by Gram-negative PG (Fig. 2a) . We obtained the same results when we used quantitative real-time PCR to assay the endogenous Dpt transcript (Fig. 2b) . In addition, the Dpt gene was not induced by Gram-negative peptidoglycan in rel E20 or rel
E20
;spz rm7 flies. These experiments confirm that Dpt induction by Gram-negative peptidoglycan is mediated exclusively by the Imd pathway.
Dpt is induced by peptidoglycan from Bacillus species
The only Gram-positive bacterial species that are known to induce Dpt expression in Drosophila are members of the Bacillus genus 7 . To determine whether the differential activation of the Imd pathway by Grampositive species is determined by differences in their peptidoglycan composition, we injected Dpt-lacZ flies with peptidoglycan purified from various Gram-positive bacteria.
Injections of peptidoglycan extracted from either Micrococcus luteus or Enterococcus faecalis did not induce expression of Dpt-lacZ as compared with water injection (Fig. 1a) . In contrast, peptidoglycan from Bacillus subtilis or Bacillus thuringiensis induced the expression of Dpt-lacZ to almost the same level induced by Gram-negative peptidoglycans (Fig. 1a, Table 1) .
These results confirm previous observations that Bacillus species induce Dpt expression 7 and indicate that this induction is due to a characteristic property of Bacillus peptidoglycan.
Muramidase-treated peptidoglycan does not induce Dpt
The above results indicate that the Imd pathway is activated by a molecular determinant present in Gram-negative bacteria and Bacillus peptidoglycans but absent in other Gram-positive peptidoglycans. Peptidoglycan is a polymer consisting of glycan strands of alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) that are crosslinked to each other by short peptide bridges 26 . Peptidoglycans from Gram-negative bacteria and Bacillus differ from other Gram-positive peptidoglycans by the replacement of lysine with a diaminopimelic acid (DAP) at the third amino acid in the peptide chain. Thus, our results show that the Imd pathway is induced by the DAP-type peptidoglycan found in Bacillus and Gram-negative bacterial species but not by the lysine-type peptidoglycan found in M. luteus and E. faecalis.
It has been shown in mammals that Nod2, a protein involved in intracellular bacterial sensing, recognizes peptidoglycan by detecting a small peptidoglycan motif, the muramyl-dipeptide (MDP) 29, 30 . To investigate whether the Imd pathway is also activated through a small peptidoglycan fragment, we monitored the expression of Dpt-lacZ after injections of E. coli and P. aeruginosa peptidoglycans that had been digested to completion with muramidase. The digested peptidoglycan showed a severely reduced ability to induce the Dpt reporter gene (Fig. 3) .
We also used high performance liquid chromatography (HPLC) to isolate the main compounds (muropeptides) released by the complete digestion of Gram-negative peptidoglycans with muramidase (monomers or dimers of disaccharide peptides with tetra-and tripeptide chains with or without 1,6-anhydro-MurNAc) and determined that none of them induced Dpt-lacZ expression (data not shown). These results suggest that polymer chain size, and possibly the three-dimensional organization of the peptidoglycan molecule, has a crucial role in recognition by the Imd pathway. Commercial LPS treated with muramidase lost its capacity to induce the Dpt-lacZ gene, indicating that the activation properties of commercial LPS preparations are indeed due to peptidoglycan contamination (Fig. 3b) .
Taken together, our data indicate that the selective activation of the Imd pathway by some bacterial strains is linked to the presence of DAP-type peptidoglycan and, unlike recognition by Nod2 in mammals, is not mediated through the detection of a small peptidoglycan motif.
Gram-negative peptidoglycan induces Dpt in mbn-2 cells
The mbn-2 cell line derived from larval hemocytes has been used extensively to study the Drosophila immune response; therefore, we tested (Fig. 4) . Also in agreement with previous studies 17, 23 , Gram-positive peptidoglycan weakly stimulated the expression of Dpt in these cells.
However, mbn-2 cells strongly expressed the Dpt gene when treated with Gram-negative peptidoglycan: the expression induced by Gramnegative peptidoglycan was 40 times higher than that induced by LPS or lysine-type peptidoglycan. These results correlate well with our in vivo data and confirm that Gram-negative peptidoglycan is the strongest inducer of the Dpt gene in mbn-2 cells.
Lysine-type peptidoglycans activate the Toll pathway
To determine which bacterial compounds activate the Toll pathway, we used the same approach described for the Imd pathway but, instead of using Dpt-lacZ, we monitored the expression of a lacZ reporter construct for the antifungal peptide gene Drs, which is a target of the Toll pathway 28 . We also assayed β-galactosidase activity in the Drs-lacZ flies18 h after injection because Drs expression peaks later than Dpt expression.
Expression of Drs-lacZ was strongly induced by injections of peptidoglycan extracted from M. luteus and E. faecalis, and this induction increased with the amount of peptidoglycan injected (Fig. 5a) . This result agrees with both previous reports that infections by Gram-positive bacteria-containing lysine-type peptidoglycans induce Drs expression 7-9 and our current observation that Drs-lacZ expression was proportional to the amount of a concentrated pellet of whole M. luteus bacteria injected into flies (Fig. 5a) . A time-course study with quantitative real-time PCR also confirmed that the endogenous Drs gene was induced more highly after Gram-positive peptidoglycan injection than after control water injection, and that Drs was induced in an acutephase profile that peaked at 24 h (Fig. 5b) . As observed for Dpt, the time course of Drs expression was similar to the kinetics of expression observed after injections of live M. luteus [7] [8] [9] , although live bacteria induced higher expression of Drs at later time points, as they did for Dpt. Gram-positive peptidoglycans also did not induce Drs after they had been digested to completion with muramidase (Fig. 3c) .
Drs induction by lysine-type peptidoglycans was dependant on the spz and PGRP-SA genes but not on the PGRP-LC and key genes (Fig.  6a) . This analysis shows that lysine-type peptidoglycan induces expression of Drs exclusively through the PGRP-SA-Toll pathway. Our results are consistent with previous data showing that the Toll pathway is strongly activated in response to Gram-positive bacterial infection and that PGRP-SA binds M. luteus peptidoglycan in vitro 15 .
Gram-negative peptidoglycan weakly activates Toll
The Imd pathway is known to have a crucial role in the response to infections of Gram-negative bacteria, but we were curious to test whether microbial compounds from Gram-negative bacteria might also activate the Toll pathway. The injection of purified LPS injection did not induce Drs-lacZ expression (Fig. 5a) ; however, this reporter gene was induced significantly after the injection of Gram-negative peptidoglycans, albeit to lower levels than those induced by lysine-type peptidoglycans.
In contrast to Dpt, which is regulated exclusively by the Imd pathway, Drs is mainly regulated by the Toll pathway but is also partially induced by the Imd pathway after infections of Gram-negative bacteria 8, 12 . To determine whether Gram-negative peptidoglycan can activate the Toll pathway, we monitored Drs expression in key 1 and PGRP-LC ∆E mutants that have defects in the Imd pathway. Flies were injected with a solution of 6 mg/ml of Gram-negative peptidoglycan, a dose that would not stimulate the Imd pathway (Fig. 1a) . This procedure allowed us to monitor the expression of Drs without any input of the Imd pathway. Quantitative real-time PCR measurements showed that Gram-negative peptidoglycan induced the Drs gene in PGRP-LC ∆E and key 1 mutants and that this induction required the spz and PGRP-SA genes, indicating that the Toll pathway is activated by Gram-negative peptidoglycan (Fig. 6b) .
Discussion
By using highly purified products, we have identified the bacterial compounds recognized by the Toll and Imd pathways. In contrast to vertebrates and the invertebrate horseshoe crab, our study suggests that LPS is not the main determinant for Gram-negative bacterial recognition in flies. We observed that enterobacterial and nonenterobacterial purified LPS samples showed no stimulatory effect on expression of the Dpt gene by the fat body in Drosophila adults. Purified LPS did induce a weak immune response in the mbn-2 cell line. The LPS response observed in mbn-2 cells was modest, however, in comparison with the stimulatory effect of Gram-negative peptidoglycans. Although we cannot exclude the possibility that the LPS also has a weak stimulatory effect in vivo that was not detected in our assay, our results indicate that peptidoglycan is the most active determinant of Gram-negative bacteria. This finding extends the results of previous studies showing that peptidoglycan but not LPS activates the prophenoloxidase cascade in the silkworm Bombyx mori 31, 32 . Our study shows that the Imd pathway is activated by specific recognition of Gram-negative and Bacillus peptidoglycans, whereas the Toll pathway is more responsive to lysine-type peptidoglycans found in most Gram-positive bacteria. Purified peptidoglycans recapitulate all of the induction properties of live Gram-negative and Gram-positive bacteria, indicating that peptidoglycan is the main bacterial product recognized by the Imd and Toll pathways. Taken together, our results show that the capacity of the Drosophila immune system to discriminate between distinct classes of bacteria by the Toll and Imd pathways is mediated through specific peptidoglycan recognition.
Our data are in keeping with the identification of PGRP-LC and PGRP-SA as putative receptors of the Imd and Toll pathway [16] [17] [18] [19] . They suggest that PGRP-LC senses a specific structure that is present in Gramnegative and Bacillus peptidoglycans but absent in other Gram-positive peptidoglycans, whereas PGRP-SA binds with higher affinity to lysinetype peptidoglycans than to DAP-type peptidoglycans. These differences between PGRP-LC and PGRP-SA provide an explanation of why the Toll pathway is more activated by infections of Gram-positive bacteria than by infections of Gram-negative bacteria.
Peptidoglycans from Bacillus and Gram-negative bacteria are crosslinked with a peptide containing a meso-DAP residue, whereas a lysine is found in the same position on other Gram-positive bacteria 33 . This variation probably results in distinct conformational differences, allowing discriminatory recognition. The observation that Bacillus peptidoglycan is a less potent inducer of the Imd pathway than Gramnegative peptidoglycan might be explained by the fact that Bacillus peptidoglycan contains a high proportion of amidated-DAP and only 3% of meso-DAP 33 . The idea of specific peptidoglycan recognition through PGRP is supported by the observation that another Drosophila PGRP, PGRP-LE, binds to DAP-type peptidoglycans but not to lysinetype peptidoglycans in vitro 20 . The stronger activation of the Toll pathway by Gram-positive bacteria with lysine-type peptidoglycan than by Gram-negative bacteria is probably accentuated during bacterial infection, because activity of the Toll pathway is proportional to peptidoglycan concentration and Grampositive bacterial cell walls contain much more peptidoglycan than do Gram-negative bacterial cell walls. It is also interesting to note that, within the range of peptidoglycan concentrations that we tested, maximum activation of the Imd pathway was reached by using at least 100 times less peptidoglycan than the dose required to strongly activate the Toll pathway. This finding may reflect the ability of the insect immune system to recognize Gram-negative bacteria efficiently even though these bacteria contain less peptidoglycan.
It is surprising that flies can detect Gram-negative bacteria on the basis of a microbial component that is present at the surface of the inner membrane and is therefore hidden by the LPS-containing outer membrane. It is possible that the Imd pathway receptor, PGRP-LC, recognizes small amounts of peptidoglycan that are continuously released by Gram-negative bacteria 34 . Alternatively, Gram-negative bacteria may be degraded by humoral or cellular mechanisms that release peptidoglycan and elicit the antimicrobial response. This latter possibility is supported by observations that P. aeruginosa cannot initiate the activation of prophenoloxidase in Galleria mellonela hemolymph unless the bacterial cells are damaged 35 . Our identification of the bacterial molecules that specifically trigger these two pathways will aid more detailed analyses of how bacterial elicitors are released and recognized during the infectious process and how Drosophila mounts specific immune responses adapted to the type of aggressor.
Two studies have shown that mammalian Nod2 functions as a general sensor of peptidoglycans through recognition of MDP, the minimal bioactive peptidoglycan motif that is common to all bacteria 29, 30 . In support of these studies, peptidoglycan treated with muramidase, an enzyme that generates small peptidoglycan fragments, induces the expression of Nod2 in cell culture (S. Girardin, personal communication). Our observations that after digestion with muramidase neither Gram-negative nor Gram-positive peptidoglycan activated an immune response in flies indicate that the bacterial sensing that regulates the synthesis of antimicrobial peptides by the Drosophila fat body is not mediated through a small peptidoglycan motif, as it is in the Nod2 system. Our study suggests that polymer chain size, and possibly the threedimensional organization of the molecule, has a crucial role in bacterial sensing, in agreement with a study showing that the minimum structure of peptidoglycan required for inducing antibacterial peptides in the silkworm B. mori is two repeating GlcNAc-MurNAc units with peptide chains 36 . We cannot, however, definitively exclude the possibility that other immune-responsive tissues (such as hemocytes) may respond to small peptidoglycan fragments.
Our study and the work on mammalian Nod2 indicate that peptidoglycan is a complex bacterial elicitor and that the innate host defense has developed several ways to detect peptidoglycan. In vertebrates, TLR2 has been also implicated in peptidoglycan sensing 22, 37 , but the precise nature of the peptidoglycan fragment recognized by TLR2 is not known. It would be worthwhile determining whether vertebrates, like the fruit fly, use distinct receptors to recognize Gram-negative and Gram-positive peptidoglycans.
Methods
Fly stocks. OR R , DD1 (y, w, P(ry+, Dpt-lacZ), P(w+, Drs-GFP)) or 8871A (w, P(w+, DrslacZ)) flies were used as wild-type strains 38 . Dpt-lacZ is a P transgene inserted on the X chromosome that contains a fusion between 2.2 kilobases (kb) of upstream sequence from the Dpt gene and the coding sequences from the gene encoding β-galactosidase 38 . Drs-lacZ is a P transgene inserted on the X chromosome that contains a fusion between 2.4 kb of upstream sequence from Drs gene and the coding sequences from β-galactosidase 38 . The spz rm7 , key 1 , PGRP-SA seml , PGRP-LC ∆E and rel E20 alleles have been described 8, 10, 16, 18, 12, 38 . We maintained fly stocks at 25 °C in standard medium.
Injection and lacZ measurements. We injected 9.2 nl of solution (water, bacterial extracts or overnight bacteria culture) into the thorax of female adults (aged 3-4 d) with a Nanoject apparatus (Drummond, Broomall, PA). After injection, flies were incubated for 6 h (Dpt-lacZ) or 18 h (Drs-lacZ) at 25 °C. Bacterial strains and LacZ measurements were done as described 7, 38 . Because the injection procedure creates an injury that by itself triggers a significant induction of the Dpt and Drs reporter genes, we normalized measurements of β-galactosidase activity after injecting microbial compounds or live bacteria to measurements obtained after injecting water under the same conditions (needle, time, experimenter). The values obtained after water injection were arbitrarily set at 100. Subtle changes in the size and sharpness of the needle affected the expression of Dpt and Drs (a larger needle generally induced higher expression of antimicrobial peptide genes). This effect explains most of the differences in the stimulation that we observed from one experiment to another. The effect of injury was less marked at later time points and consequently had less influence on Drs expression.
Bacterial products and bacterial strains. Commercial LPS (Sigma, St. Louis, MO) from E. coli 055:B5 was used either directly or after treatment with muramidase. LPS from E. coli 0111B4, S. typhimurium LT2 and B. pertussis was highly purified. The purification steps involved the extraction of phospholipids with chloroform/methanol (1:2) followed by treatment with DNase, RNase and then protease until thin-layer chromatography and ultraviolet spectra showed no detectable contaminants 39 . We check the electrophoretic behavior and mass of all purified samples by SDS-PAGE and mass spectrometry, respectively 40 . Purified LPS from S. typhimurium LT2 was used directly, whereas E. coli 0111B4 and B. pertussis LPS were treated by a procedure that improves LPS solubility by removing divalent cations that form links between molecules 41 . This procedure rules out erroneous results arising from aggregation.
Purified peptidoglycans were obtained from cultures of E. coli (1106), P. aeruginosa (PAO1), M. luteus, E. faecalis, B. thuringiensis and B. subtilis grown overnight at 37 °C in LB medium. Cultures were stopped by rapid chilling to 0-4 °C. Collected cells were washed with a cold 0.85% NaCl solution and centrifuged again. We then rapidly suspended the bacteria with vigorous stirring in 20 ml of a hot (95-100 °C) aqueous solution of 4% SDS for 30 min. After standing overnight at 20 °C, the suspensions were centrifuged for 30 min at 200,000g in a Beckman TL100 centrifuge and the pellets were washed several times with water. Final suspensions were made in 2 ml of water and aliquots (100 µl) were hydrolyzed and analyzed with a Hitachi L8800 amino acid analyzer. The peptidoglycan content of the sacculi was expressed in terms of its muramic acid content. We treated the crude preparations successively with pancreatin, pronase and trypsin (Sigma) to eliminate peptidoglycan-associated proteins 27 . Hydrolysis of an aliquot of the peptidoglycan preparations after several washings in water showed that they contained only peptidoglycan constituents, muramic acid, glucosamine, alanine, glutamic acid and diaminopimelic acid or lysine, in the expected molar ratios.
Peptidoglycans were digested by overnight treatment with the muramidase mutanolysin (Sigma) and the reaction was stopped by incubating samples in a boiling water bath for 5 min. We reduced the resulting soluble fragments (muropeptides) with sodium borohydride and separated them by reverse-phase HPLC as described 26 . MDP (MurNAc-L-Ala-D-isoGln) was obtained from Calbiochem (La Jolla, CA) and MurNAc peptides were generated by mild acid hydrolysis of UDP-MurNAc peptides in 0.1 M HCl for 10 min at 95 °C. The E. coli mutant strain BW25113 ∆lpp:Cm R , in which the whole lpp gene was replaced with an antibiotic (chloramphenicol) resistance gene, was created as described 42 . The oligonucleotides used for PCR amplification of the antibiotic resistance gene flanked by sequences designed for specific disruption of the lpp gene were 5′-CGC TAC ATG GAG ATT AAC TCA ATC TAG AGG GTA TTA ATA ATG AAA GCT ACA TAT GAA TAT CCT CCT TAG-3′ and 5′-GGC GCA CAA TGT GCG CCA TTT TTC ACT TCA CAG GTA CTA TTA CTT GCG GGT GTA GGC TGG AGC TGC TTC-3′. Quantitative real-time PCR. Total RNA was extracted with RNAzol reagent (Invitrogen, Carlsbad, CA). Complementary DNA was synthesized by using the First cDNA synthesis kit (Roche, Basel, Switzerland) in accordance with manufacturer's instructions. For quantitative analysis of Dpt expression, fluorescence real-time PCR was done with the doublestranded DNA dye SYBR Green (Perkin Elmer, Boston MA). Primer pairs for Dpt (sense, 5′-GGC TTA TCC GAT GCC CGA CG-3′; antisense, 5′-TCT GTA GGT GTA GGT GCT TCC C-3′) and control Rac2 (sense, 5′-CAG ACG ATC GAG AAG CTG AAG G-3′; antisense, 5′-GTG CCG CTT GGG TCC TCG AAC G-3′) were used to detect target gene transcripts. We analyzed SYBR Green with an ABI PRISM 7700 system (Perkin Elmer) in accordance with the manufacturer's instructions. All samples were analyzed in triplicate, and the amount of messenger RNA detected was normalized to control Rac2 mRNA values. We used normalized data to quantity the relative levels of a given mRNA according to cycling threshold (∆Ct) analysis.
To quantify Drs and Dpt mRNA in whole animals, we extracted RNA with RNA TRIzol (Invitrogen). cDNAs were synthesized with SuperScript II (Invitrogen) and PCR was done with the double-stranded DNA dye SYBR Green I (Roche) Primer pairs for Dpt (sense, 5′-GCT GCG CAA TCG CTT CTA CT-3′; antisense, 5′-TGG TGG AGT GGG CTT CAT G -3′), Drs (sense, 5′-CGT GAG AAC CTT TTC CAA TAT GAT G-3′; antisense, 5′-TCC CAG GAC CAC CAG CAT-3′) and control Rp49 (sense, 5′-GAC GCT TCA AGG GAC AGT ATC TG-3′; antisense, 5′-AAA CGC GGT TCT GCA TGA G-3′) were used to detect target gene transcripts. SYBR Green was analyzed on a Lightcycler (Roche).
